Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |